SCHEMBL28196751

SCHEMBL28196751

CCNC(=O)Nc1cc(C)cs1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.46
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 5/20 0.40
TP53 P04637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PKM P14618 2/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DAO P14920 1/20 0.39
ABL1 P00519 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28197504 0.84 POLB (0.49) KMT2AMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11692597 0.82 ALDH1A1 (0.45) RAF1MEN1KMT2AMAPTKDM4E
SCHEMBL28855342 0.82 RAF1 (0.49) RAF1MEN1KMT2AMAPTKDM4E
SCHEMBL28197567 0.80 RAF1 (0.47) RAF1MEN1KMT2AMAPTKDM4E
SCHEMBL8031103 0.79 TSHR (0.44) RAF1MEN1KMT2AGAATP53
SCHEMBL1694410 0.77 DAO (0.52) RAF1MEN1KMT2AMAPTGAA
SCHEMBL28196781 0.77 RAF1 (0.45) RAF1MEN1KMT2AGAATP53
SCHEMBL29183917 0.76 CYP1A2 (0.51) RAF1MEN1KMT2AMAPTKDM4E
SCHEMBL28196767 0.76 GAA (0.54) RAF1MEN1KMT2AMAPTGAA
SCHEMBL11471040 0.76 HSD17B10 (0.48) RAF1MEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105793267-B Cyclic thienouracil carboxamides and their use 拜耳制药股份公司 2018-02-06 CN disclosed
CN-107646035-A Heterocyclyl methyl thieno uracil as adenosine A 2B receptor antagonists 拜耳制药股份公司 2018-01-30 CN disclosed